And here in the U.S. the Obama administration recently brought together the heads of several government agencies to mark the release of a coordinated federal plan to deal with the nation's growing prescription drug abuse epidemic.
Under the plan the FDA would require drug manufacturers to develop education programs for prescribers to help them identify, treat, and end dependence on prescription drugs. The plan notes that while there are a number of classes of prescription drugs that are abused, it “primarily focuses on the growing and often deadly problem of prescription opioid abuse.” At the heart of the plan is the requirement that drug manufacturers provide educational programs to those licensed to prescribe long-acting and extended-release opioids. In addition, manufacturers would be required to provide materials to assist physicians in counseling patients in the proper use and risks of these drugs.
APA, the American Academy of Addiction Psychiatry (AAAP), and the American Osteopathic Academy of Addiction Medicine (AOAAM) released a joint statement applauding the plan. For more information see Psychiatric News http://pn.psychiatryonline.org/content/46/10/1.1.full